Related Experiment Videos
[Resection of the lung in tuberculosis].
Vestnik Khirurgii Imeni I. I. Grekova
|October 1, 1976
Summary
Surgical treatment for fibrous-cavernous tuberculosis in 175 patients showed positive outcomes, with 99 achieving a complete cure. Preoperative ascorbic acid helped minimize complications, demonstrating its value in managing this severe form of tuberculosis.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Infectious Diseases
Background:
- Fibrous-cavernous tuberculosis is a severe, chronic form of tuberculosis.
- Surgical intervention is considered for advanced or refractory cases.
- Effective preoperative and postoperative management is crucial for patient outcomes.
Observation:
- The study analyzed surgical treatment outcomes in 175 patients with fibrous-cavernous tuberculosis.
- 92 patients had fibrous-cavernous tuberculosis; 2 underwent bilateral pulmonary resection.
- Preoperative management included high-dose ascorbic acid to prevent capillary hemorrhages.
Findings:
- Postoperative complications occurred in 23 patients, with 20 successfully managed.
- There were 3 deaths among the 175 patients.
- A complete cure was achieved in 99 patients, with considerable improvement in 71 and some improvement in 2.
- Late follow-up (1-4 years) in 160 patients revealed recurrent tuberculosis in 6 cases.
Implications:
- Surgical treatment can be effective for fibrous-cavernous tuberculosis, offering a cure or significant improvement for most patients.
- The use of ascorbic acid appears beneficial in reducing postoperative bleeding complications.
- Long-term monitoring is essential to detect and manage potential tuberculosis recurrence after surgery.